Codes / ICD10CM / M48.14

M48.14 Ankylosing hyperostosis [Forestier], thoracic region

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Ankylosing Hyperostosis [Forestier], Thoracic Region

Summary

Ankylosing hyperostosis, also known as Forestier disease, is a condition characterized by abnormal calcification and ossification of ligaments and entheses, particularly in the spine. This process leads to the formation of bony outgrowths (osteophytes) that can cause stiffness and reduced mobility. The condition primarily affects the anterior longitudinal ligament, resulting in a "flowing" pattern of ossification along the vertebral bodies, with this code specifying involvement of the thoracic region.

Causes

The exact cause of ankylosing hyperostosis is not fully understood, but it is associated with age-related degenerative changes and metabolic factors. It may involve abnormal bone formation in response to mechanical stress or inflammation, though it is not considered an inflammatory arthritis like ankylosing spondylitis. Genetic predisposition and metabolic conditions may also play a role.

Risk Factors

  • Advanced age, typically affecting individuals over 50.
  • Male gender, as the condition is more common in men.
  • Obesity or mechanical stress on the spine.
  • Metabolic disorders that influence bone health.

Symptoms

  • Progressive stiffness and pain in the thoracic spine.
  • Reduced range of motion in the back.
  • Possible difficulty with breathing if the ossification affects the rib cage.
  • Minimal inflammation compared to other spinal disorders.

Diagnosis

Diagnosis is typically based on clinical evaluation and imaging studies, such as X-rays or CT scans, which reveal characteristic flowing osteophytes along the thoracic spine. Physical examination may assess spinal mobility and rule out other conditions. Laboratory tests are generally not required unless metabolic disorders are suspected.

Treatment Options

Treatment focuses on managing symptoms and maintaining mobility. Options may include:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and stiffness.
  • Physical therapy to improve flexibility and strength.
  • Lifestyle modifications, such as weight management and ergonomic adjustments.
  • In severe cases, surgical intervention may be considered to relieve compression or improve mobility.

Prognosis and Follow-Up

The condition typically progresses slowly, with symptoms often stabilizing over time. Most patients maintain functional independence, though stiffness may persist. Regular follow-up with a healthcare provider is recommended to monitor symptoms and adjust treatment as needed.

Complications

  • Chronic pain and reduced mobility.
  • Potential respiratory issues if the rib cage is affected.
  • Rarely, compression of nearby structures, such as nerves or the esophagus.

Lifestyle & Prevention

  • Engage in regular low-impact exercise to maintain spinal flexibility.
  • Maintain a healthy weight to reduce mechanical stress on the spine.
  • Use ergonomic supports, such as supportive chairs or mattresses.
  • Avoid activities that exacerbate spinal strain.

When to Seek Professional Help

Seek medical attention if you experience:

  • Progressive spinal stiffness or pain that interferes with daily activities.
  • Difficulty breathing or swallowing.
  • Sudden changes in mobility or new neurological symptoms.

Tips for Medical Coders

When coding for M48.14, ensure documentation specifies the thoracic region involvement. The code is site-specific and should not be used if the location is unspecified or affects other regions. Verify that the diagnosis aligns with imaging findings of flowing osteophytes in the thoracic spine to support accurate coding.

Book a walkthrough

M48.14 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.